🇺🇸 FDA
Patent

US 12060350

Therapeutic compounds and methods of use thereof

granted A61KA61K2039/55511A61K39/39

Quick answer

US patent 12060350 (Therapeutic compounds and methods of use thereof) held by Regents of the University of Minnesota expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/55511, A61K39/39, A61K47/545, A61K47/61